Product logins

Find logins to all Clarivate products below.


chevron_left

Global Biosurgical Agent Market

Medtech Resource Center
Global Biosurgical Agent Market

The ease-of-use, high cost-effectiveness, reduced patient readmission rates, and rising physician awareness of ORC-based hemostats will continue to drive growth in the market.

Orthopedic procedures have the highest penetration rate of biosurgical agents, primarily due to the rising demand for minimally invasive surgeries. In 2023, orthopedic procedures accounted for approximately 39% of total biosurgical agent units sold, and this trend is expected to continue throughout the forecast period.

Read our Market Snapshot to access data and analysis on the state of the global biosurgical agent market from 2019 through 2033.

 

Related insights

The latest news, technologies, and resources from our team.

United States Transcatheter Mitral and Tricuspid Valve Device Market Snapshot United States Transcatheter Mitral and Tricuspid Valve Device Market Snapshot
United States Transcatheter Mitral and Tricuspid Valve Device Market Snapshot
Europe Interventional Oncology Device Market Snapshot Europe Interventional Oncology Device Market Snapshot
Europe Interventional Oncology Device Market Snapshot
Latin America Trauma Device Market Snapshot Latin America Trauma Device Market Snapshot
Latin America Trauma Device Market Snapshot
chevron_left
chevron_right